Skip to main content
SpringerLink
Log in

Third mRNA COVID-19 vaccine dose well tolerated in infants and young children

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hause AM, et al. Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023. Morbidity and Mortality Weekly Report 72: 621-626, No. 23, et al. Jun 2023. Available from: URL: http://doi.org/10.15585/mmwr.mm7223a2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Third mRNA COVID-19 vaccine dose well tolerated in infants and young children. Reactions Weekly 1961, 12 (2023). https://doi.org/10.1007/s40278-023-41269-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-41269-9

Search

Navigation